|
OMIM |
Link |
Information gain |
01 |
|
SLE
|
[NCBI]
|
0.0100697
|
|
|
CVID
|
[NCBI]
|
0.00368148
|
|
|
BCGF
|
[NCBI]
|
0.00317324
|
|
|
BL
|
[NCBI]
|
0.00298799
|
|
|
RA
|
[NCBI]
|
0.00274696
|
|
|
scott syndrome
|
[NCBI]
|
0.00209948
|
|
|
CF
|
[NCBI]
|
0.00146187
|
|
|
sjogren syndrome
|
[NCBI]
|
0.00126839
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.00123198
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.00123198
|
|
|
vitamin d-dependent rickets, type ii, with normal vitamin d receptor
|
[NCBI]
|
0.00123198
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.00119501
|
|
|
behcet syndrome
|
[NCBI]
|
0.00110433
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000990631
|
|
|
AD
|
[NCBI]
|
0.000986794
|
|
|
WAS
|
[NCBI]
|
0.000859233
|
|
|
MG
|
[NCBI]
|
0.000762613
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
0.000759474
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
0.00071812
|
|
|
reticular dysgenesia
|
[NCBI]
|
0.000674332
|
|
|
pygmy
|
[NCBI]
|
0.000674332
|
|
|
BTK
|
[NCBI]
|
0.000665592
|
|
|
NAD
|
[NCBI]
|
0.000630071
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.000630071
|
|
|
IDDM
|
[NCBI]
|
0.0006147
|
|
|
TNFSF13B
|
[NCBI]
|
0.000606301
|
|
|
immune defect due to absence of thymus
|
[NCBI]
|
0.000593416
|
|
|
IGAD1
|
[NCBI]
|
0.000593416
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000593416
|
|
|
IL2
|
[NCBI]
|
0.000547422
|
|
|
HIGM1
|
[NCBI]
|
0.000529985
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
0.000512841
|
|
|
AICDA
|
[NCBI]
|
0.000498436
|
|
|
ADA
|
[NCBI]
|
0.000485127
|
|
|
CLL
|
[NCBI]
|
0.000485111
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000454621
|
|
|
EGF
|
[NCBI]
|
0.00042032
|
|
|
TNF
|
[NCBI]
|
0.000419853
|
|
|
VRNI
|
[NCBI]
|
0.000410644
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
0.000410233
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
0.000410233
|
|
|
EBF
|
[NCBI]
|
0.000405848
|
|
|
PAX5
|
[NCBI]
|
0.000375027
|
|
|
TLR9
|
[NCBI]
|
0.00037033
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.000369503
|
|
|
BCL2
|
[NCBI]
|
0.000354792
|
|
|
IL4
|
[NCBI]
|
0.00034667
|
|
|
CXCL13
|
[NCBI]
|
0.000344382
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
0.000340112
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
0.00031797
|
|
|
CMM
|
[NCBI]
|
0.000288768
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
0.000287296
|
|
|
CD19
|
[NCBI]
|
0.000279239
|
|
|
SCIDX1
|
[NCBI]
|
0.000278201
|
|
|
TNFRSF13C
|
[NCBI]
|
0.000246406
|
|
|
BLNK
|
[NCBI]
|
0.000245067
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
0.000244683
|
|
|
XLP1
|
[NCBI]
|
0.00024337
|
|
|
VEGF
|
[NCBI]
|
0.000242026
|
|
|
JAK3
|
[NCBI]
|
0.000223399
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
0.000213841
|
|
|
IL7R
|
[NCBI]
|
0.00021334
|
|
|
ACHE
|
[NCBI]
|
0.000208663
|
|
|
t-cell subgroups, non-hla-linked
|
[NCBI]
|
0.000205076
|
|
|
NPY
|
[NCBI]
|
0.000200086
|
|
|
TNFRSF13B
|
[NCBI]
|
0.000194785
|
|
|
MAFD1
|
[NCBI]
|
0.000192255
|
|
|
CD40
|
[NCBI]
|
0.000180574
|
|
|
TNFSF6
|
[NCBI]
|
0.000178971
|
|
|
CJD
|
[NCBI]
|
0.000177167
|
|
|
IL7
|
[NCBI]
|
0.000176561
|
|
|
BLR1
|
[NCBI]
|
0.000169426
|
|
|
EGFR
|
[NCBI]
|
0.000164854
|
|
|
AVP
|
[NCBI]
|
0.000161433
|
|
|
SH2D1A
|
[NCBI]
|
0.000160302
|
|
|
RAG1
|
[NCBI]
|
0.000157237
|
|
|
NP
|
[NCBI]
|
0.000152859
|
|
|
human herpesvirus type 6, integrated
|
[NCBI]
|
0.000151743
|
|
|
icos deficiency
|
[NCBI]
|
0.000151743
|
|
|
TCF3
|
[NCBI]
|
0.000149437
|
|
|
BCL6
|
[NCBI]
|
0.000145148
|
|
|
GFAP
|
[NCBI]
|
0.000143398
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
0.000133589
|
|
|
HLA-DRA
|
[NCBI]
|
0.00012978
|
|
|
MBP
|
[NCBI]
|
0.000124041
|
|
|
CCR7
|
[NCBI]
|
0.00012381
|
|
|
POU2AF1
|
[NCBI]
|
0.00012381
|
|
|
CHAT
|
[NCBI]
|
0.000119095
|
|
|
IKZF3
|
[NCBI]
|
0.000116493
|
|
|
PTH
|
[NCBI]
|
0.000115387
|
|
|
CCL21
|
[NCBI]
|
0.000114679
|
|
|
HLA-DQA1
|
[NCBI]
|
0.000114653
|
|
|
FCGR2B
|
[NCBI]
|
0.000113889
|
|
|
HLA-DPA1
|
[NCBI]
|
0.000109843
|
|
|
IL2RG
|
[NCBI]
|
0.000107771
|
|
|
IGLL1
|
[NCBI]
|
0.000107075
|
|
|
BLK
|
[NCBI]
|
0.000107075
|
|
|
CD22
|
[NCBI]
|
0.000107075
|
|
|
IGAD2
|
[NCBI]
|
0.000102528
|
|
|
immunodeficiency with hyper-igm, type 4
|
[NCBI]
|
0.000102528
|
|
|
b-cell immunodeficiency, distal limb anomalies, and urogenital malformations
|
[NCBI]
|
0.000102528
|
|
|
immune deficiency, familial variable
|
[NCBI]
|
0.000102528
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
0.000102528
|
|
|
HLA-DO
|
[NCBI]
|
0.000100827
|
|
|
phosphoinositide 3-kinase adaptor protein 1
|
[NCBI]
|
0.000100827
|
|
|
VPREB1
|
[NCBI]
|
0.000100827
|
|
|
RAG2
|
[NCBI]
|
9.99832e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
9.99488e-05
|
|
|
LAT
|
[NCBI]
|
9.94835e-05
|
|
|
AR
|
[NCBI]
|
9.5822e-05
|
|
|
TG
|
[NCBI]
|
9.52473e-05
|
|
|
TNFSF13
|
[NCBI]
|
9.47806e-05
|
|
|
SLEB1
|
[NCBI]
|
9.0269e-05
|
|
|
IL5
|
[NCBI]
|
8.94849e-05
|
|
|
CXCR4
|
[NCBI]
|
8.56857e-05
|
|
|
BACH2
|
[NCBI]
|
8.46958e-05
|
|
|
HLA-MT
|
[NCBI]
|
8.46958e-05
|
|
|
CD79B
|
[NCBI]
|
8.46958e-05
|
|
|
TRAF2
|
[NCBI]
|
8.33455e-05
|
|
|
LTK
|
[NCBI]
|
8.29927e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
8.11867e-05
|
|
|
SPI1
|
[NCBI]
|
7.99792e-05
|
|
|
NGFB
|
[NCBI]
|
7.95138e-05
|
|
|
IGHG1
|
[NCBI]
|
7.78242e-05
|
|
|
MHC2TA
|
[NCBI]
|
7.72675e-05
|
|
|
MS4A1
|
[NCBI]
|
7.67288e-05
|
|
|
TNFRSF17
|
[NCBI]
|
7.67288e-05
|
|
|
TLR7
|
[NCBI]
|
7.50086e-05
|
|
|
ICOS
|
[NCBI]
|
7.48031e-05
|
|
|
BDNF
|
[NCBI]
|
7.43877e-05
|
|
|
CR1
|
[NCBI]
|
7.25453e-05
|
|
|
PTPRC
|
[NCBI]
|
7.24174e-05
|
|
|
CR2
|
[NCBI]
|
7.10798e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
7.10798e-05
|
|
|
WBSCR5
|
[NCBI]
|
7.10798e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 2
|
[NCBI]
|
6.72142e-05
|
|
|
BANK1
|
[NCBI]
|
6.72142e-05
|
|
|
GCET2
|
[NCBI]
|
6.72142e-05
|
|
|
LY64
|
[NCBI]
|
6.72142e-05
|
|
|
H2AFX
|
[NCBI]
|
6.67286e-05
|
|
|
DCLRE1C
|
[NCBI]
|
6.66722e-05
|
|
|
LYN
|
[NCBI]
|
6.66722e-05
|
|
|
CRH
|
[NCBI]
|
6.58875e-05
|
|
|
caspase 8 deficiency
|
[NCBI]
|
6.40204e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
6.40204e-05
|
|
|
bare lymphocyte syndrome, type i
|
[NCBI]
|
6.40204e-05
|
|
|
t-cell immunodeficiency, congenital alopecia, and nail dystrophy
|
[NCBI]
|
6.40204e-05
|
|
|
IL21R
|
[NCBI]
|
6.30518e-05
|
|
|
FCER2
|
[NCBI]
|
6.30518e-05
|
|
|
BCL10
|
[NCBI]
|
6.30518e-05
|
|
|
CFTR
|
[NCBI]
|
6.20417e-05
|
|
|
KLK3
|
[NCBI]
|
6.15093e-05
|
|
|
TPO
|
[NCBI]
|
6.0393e-05
|
|
|
KITLG
|
[NCBI]
|
6.02895e-05
|
|
|
IL6
|
[NCBI]
|
6.00143e-05
|
|
|
PRKCD
|
[NCBI]
|
5.9979e-05
|
|
|
VAV1
|
[NCBI]
|
5.73102e-05
|
|
|
YY1
|
[NCBI]
|
5.73102e-05
|
|
|
MIRN155
|
[NCBI]
|
5.73102e-05
|
|
|
CD80
|
[NCBI]
|
5.73102e-05
|
|
|
PRKDC
|
[NCBI]
|
5.67111e-05
|
|
|
INPP5D
|
[NCBI]
|
5.67111e-05
|
|
|
IGKC
|
[NCBI]
|
5.67111e-05
|
|
|
DNTT
|
[NCBI]
|
5.54771e-05
|
|
|
MPO
|
[NCBI]
|
5.49716e-05
|
|
|
IGLC1
|
[NCBI]
|
5.49524e-05
|
|
|
IRF4
|
[NCBI]
|
5.49524e-05
|
|
|
CSTF2
|
[NCBI]
|
5.35302e-05
|
|
|
LSP1
|
[NCBI]
|
5.35302e-05
|
|
|
ews/fli1-activated transcript 2
|
[NCBI]
|
5.35302e-05
|
|
|
IGJ
|
[NCBI]
|
5.35302e-05
|
|
|
BST1
|
[NCBI]
|
5.35302e-05
|
|
|
LRRC8
|
[NCBI]
|
5.35302e-05
|
|
|
XBP1
|
[NCBI]
|
5.28415e-05
|
|
|
CD40LG
|
[NCBI]
|
5.23539e-05
|
|
|
ZAP70
|
[NCBI]
|
5.09317e-05
|
|
|
LIG4
|
[NCBI]
|
5.09317e-05
|
|
|
TCL1A
|
[NCBI]
|
5.09317e-05
|
|
|
PRL
|
[NCBI]
|
4.99942e-05
|
|
|
west nile virus, susceptibility to
|
[NCBI]
|
4.99654e-05
|
|
|
interleukin 2 receptor, alpha, deficiency of
|
[NCBI]
|
4.99654e-05
|
|
|
ALPS
|
[NCBI]
|
4.98355e-05
|
|
|
CXCL12
|
[NCBI]
|
4.86397e-05
|
|
|
IL13
|
[NCBI]
|
4.77918e-05
|
|
|
CD72
|
[NCBI]
|
4.73829e-05
|
|
|
SLAMF6
|
[NCBI]
|
4.73829e-05
|
|
|
RGS1
|
[NCBI]
|
4.73829e-05
|
|
|
RFXANK
|
[NCBI]
|
4.73829e-05
|
|
|
CENPM
|
[NCBI]
|
4.73829e-05
|
|
|
HGF
|
[NCBI]
|
4.67041e-05
|
|
|
CLDN11
|
[NCBI]
|
4.47269e-05
|
|
|
MYC
|
[NCBI]
|
4.41933e-05
|
|
|
WIPF1
|
[NCBI]
|
4.34401e-05
|
|
|
WAS
|
[NCBI]
|
4.32436e-05
|
|
|
IGHM
|
[NCBI]
|
4.31841e-05
|
|
|
RFXAP
|
[NCBI]
|
4.31841e-05
|
|
|
TRAF3
|
[NCBI]
|
4.31841e-05
|
|
|
b-cell rag-associated gene
|
[NCBI]
|
4.31841e-05
|
|
|
MCM3AP
|
[NCBI]
|
4.31841e-05
|
|
|
BAD
|
[NCBI]
|
4.31841e-05
|
|
|
SLA
|
[NCBI]
|
4.31841e-05
|
|
|
MSC
|
[NCBI]
|
4.31841e-05
|
|
|
CCL4L1
|
[NCBI]
|
4.31841e-05
|
|
|
GDNF
|
[NCBI]
|
4.28584e-05
|
|
|
WBS
|
[NCBI]
|
4.25904e-05
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
4.11632e-05
|
|
|
severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation
|
[NCBI]
|
4.11079e-05
|
|
|
NFATC1
|
[NCBI]
|
4.10981e-05
|
|
|
UNG
|
[NCBI]
|
4.10981e-05
|
|
|
STAT6
|
[NCBI]
|
4.09571e-05
|
|
|
PRKCM
|
[NCBI]
|
4.03876e-05
|
|
|
PRKCB1
|
[NCBI]
|
3.99823e-05
|
|
|
IRF5
|
[NCBI]
|
3.99823e-05
|
|
|
CLEC4A
|
[NCBI]
|
3.99823e-05
|
|
|
CCL25
|
[NCBI]
|
3.90118e-05
|
|
|
GTS
|
[NCBI]
|
3.80634e-05
|
|
|
TLR4
|
[NCBI]
|
3.75424e-05
|
|
|
IL21
|
[NCBI]
|
3.73943e-05
|
|
|
RFX5
|
[NCBI]
|
3.73943e-05
|
|
|
ITGAL
|
[NCBI]
|
3.73943e-05
|
|
|
LILRB1
|
[NCBI]
|
3.73943e-05
|
|
|
MYD88
|
[NCBI]
|
3.62605e-05
|
|
|
VIP
|
[NCBI]
|
3.61714e-05
|
|
|
TNFSF8
|
[NCBI]
|
3.54269e-05
|
|
|
SOX4
|
[NCBI]
|
3.52241e-05
|
|
|
CD3D
|
[NCBI]
|
3.52241e-05
|
|
|
TNFSF7
|
[NCBI]
|
3.52241e-05
|
|
|
MAP3K14
|
[NCBI]
|
3.52241e-05
|
|
|
ITGB2
|
[NCBI]
|
3.51534e-05
|
|
|
AITD3
|
[NCBI]
|
3.4719e-05
|
|
|
whim syndrome
|
[NCBI]
|
3.4719e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
3.4719e-05
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
3.4719e-05
|
|
|
PBC
|
[NCBI]
|
3.4719e-05
|
|
|
CTLA4
|
[NCBI]
|
3.38655e-05
|
|
|
ENPEP
|
[NCBI]
|
3.37407e-05
|
|
|
b-cell novel protein 1
|
[NCBI]
|
3.36052e-05
|
|
|
IBTK
|
[NCBI]
|
3.36052e-05
|
|
|
MIRN150
|
[NCBI]
|
3.36052e-05
|
|
|
md1 protein
|
[NCBI]
|
3.36052e-05
|
|
|
ANKS1B
|
[NCBI]
|
3.36052e-05
|
|
|
NUDCD1
|
[NCBI]
|
3.36052e-05
|
|
|
ada2, yeast, homolog of, beta
|
[NCBI]
|
3.36052e-05
|
|
|
EBI2
|
[NCBI]
|
3.36052e-05
|
|
|
VPREB3
|
[NCBI]
|
3.36052e-05
|
|
|
8d6 antigen
|
[NCBI]
|
3.36052e-05
|
|
|
C4ORF7
|
[NCBI]
|
3.36052e-05
|
|
|
SLA2
|
[NCBI]
|
3.36052e-05
|
|
|
REXO1
|
[NCBI]
|
3.36052e-05
|
|
|
fc receptor-like protein 1
|
[NCBI]
|
3.36052e-05
|
|
|
immunoglobulin superfamily receptor translocation-associated gene 1
|
[NCBI]
|
3.36052e-05
|
|
|
GTF2F2
|
[NCBI]
|
3.36052e-05
|
|
|
proapoptotic caspase adaptor protein
|
[NCBI]
|
3.36052e-05
|
|
|
unc112-related protein 2
|
[NCBI]
|
3.36052e-05
|
|
|
deubiquitinating enzyme 3
|
[NCBI]
|
3.36052e-05
|
|
|
renal ubiquitous protein 1
|
[NCBI]
|
3.36052e-05
|
|
|
px19, chicken, homolog of
|
[NCBI]
|
3.36052e-05
|
|
|
bcr downstream signaling 1
|
[NCBI]
|
3.36052e-05
|
|
|
SGPL1
|
[NCBI]
|
3.36052e-05
|
|
|
IGHG4
|
[NCBI]
|
3.36052e-05
|
|
|
fc receptor-like protein 2
|
[NCBI]
|
3.36052e-05
|
|
|
HSPA4
|
[NCBI]
|
3.36052e-05
|
|
|
at-hook transcription factor akna
|
[NCBI]
|
3.36052e-05
|
|
|
MB1
|
[NCBI]
|
3.36052e-05
|
|
|
PEG10
|
[NCBI]
|
3.33572e-05
|
|
|
ICAM1
|
[NCBI]
|
3.31324e-05
|
|
|
IKBKG
|
[NCBI]
|
3.2428e-05
|
|
|
DHFR
|
[NCBI]
|
3.18012e-05
|
|
|
POMC
|
[NCBI]
|
3.04445e-05
|
|
|
HMGA1
|
[NCBI]
|
3.02656e-05
|
|
|
TNFRSF9
|
[NCBI]
|
3.02656e-05
|
|
|
RBPSUH
|
[NCBI]
|
3.02656e-05
|
|
|
TNFSF4
|
[NCBI]
|
3.02656e-05
|
|
|
PAG1
|
[NCBI]
|
3.02656e-05
|
|
|
TRAF1
|
[NCBI]
|
3.02656e-05
|
|
|
FSCN1
|
[NCBI]
|
3.02656e-05
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
2.97841e-05
|
|
|
PCNA
|
[NCBI]
|
2.97201e-05
|
|
|
CNTF
|
[NCBI]
|
2.93289e-05
|
|
|
SLAMF1
|
[NCBI]
|
2.92729e-05
|
|
|
MCF2
|
[NCBI]
|
2.89567e-05
|
|
|
BCL2L11
|
[NCBI]
|
2.89567e-05
|
|
|
ID3
|
[NCBI]
|
2.89567e-05
|
|
|
TAP1
|
[NCBI]
|
2.89567e-05
|
|
|
IL8RB
|
[NCBI]
|
2.89567e-05
|
|
|
ICOSLG
|
[NCBI]
|
2.89567e-05
|
|
|
LAD
|
[NCBI]
|
2.88767e-05
|
|
|
FTCD
|
[NCBI]
|
2.77682e-05
|
|
|
PRDM1
|
[NCBI]
|
2.77682e-05
|
|
|
MNDA
|
[NCBI]
|
2.77682e-05
|
|
|
AHR
|
[NCBI]
|
2.71193e-05
|
|
|
LIP
|
[NCBI]
|
2.69615e-05
|
|
|
PIK3CG
|
[NCBI]
|
2.66809e-05
|
|
|
ADCYAP1
|
[NCBI]
|
2.60121e-05
|
|
|
GS1
|
[NCBI]
|
2.58098e-05
|
|
|
ID1
|
[NCBI]
|
2.56795e-05
|
|
|
PIK3R1
|
[NCBI]
|
2.56795e-05
|
|
|
FLT3
|
[NCBI]
|
2.56795e-05
|
|
|
MOG
|
[NCBI]
|
2.56795e-05
|
|
|
HPS
|
[NCBI]
|
2.56704e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.49648e-05
|
|
|
MAPK9
|
[NCBI]
|
2.47522e-05
|
|
|
IRF7
|
[NCBI]
|
2.47522e-05
|
|
|
CCL19
|
[NCBI]
|
2.47522e-05
|
|
|
SEMA4D
|
[NCBI]
|
2.47522e-05
|
|
|
GAPDH
|
[NCBI]
|
2.45157e-05
|
|
|
TBX21
|
[NCBI]
|
2.38894e-05
|
|
|
MME
|
[NCBI]
|
2.38894e-05
|
|
|
BCL7A
|
[NCBI]
|
2.36896e-05
|
|
|
DGCR6
|
[NCBI]
|
2.36896e-05
|
|
|
BST2
|
[NCBI]
|
2.36896e-05
|
|
|
SNRPD1
|
[NCBI]
|
2.36896e-05
|
|
|
ARHGEF1
|
[NCBI]
|
2.36896e-05
|
|
|
ZNF271
|
[NCBI]
|
2.36896e-05
|
|
|
CD37
|
[NCBI]
|
2.36896e-05
|
|
|
ebna2 coactivator p100
|
[NCBI]
|
2.36896e-05
|
|
|
TNFSF5IP1
|
[NCBI]
|
2.36896e-05
|
|
|
immunity-associated protein 4
|
[NCBI]
|
2.36896e-05
|
|
|
TANK
|
[NCBI]
|
2.36896e-05
|
|
|
ZFAT1
|
[NCBI]
|
2.36896e-05
|
|
|
POLQ
|
[NCBI]
|
2.36896e-05
|
|
|
IL4I1
|
[NCBI]
|
2.36896e-05
|
|
|
SPIB
|
[NCBI]
|
2.36896e-05
|
|
|
CD79A
|
[NCBI]
|
2.36896e-05
|
|
|
LAG3
|
[NCBI]
|
2.36896e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
2.36896e-05
|
|
|
PSMA6
|
[NCBI]
|
2.36896e-05
|
|
|
ARID3A
|
[NCBI]
|
2.36896e-05
|
|
|
fc receptor homolog expressed in b cells
|
[NCBI]
|
2.36896e-05
|
|
|
LY96
|
[NCBI]
|
2.36896e-05
|
|
|
SLAMF7
|
[NCBI]
|
2.36896e-05
|
|
|
PTPRD
|
[NCBI]
|
2.36896e-05
|
|
|
PILRB
|
[NCBI]
|
2.36896e-05
|
|
|
HLA-DMB
|
[NCBI]
|
2.36896e-05
|
|
|
NFAM1
|
[NCBI]
|
2.36896e-05
|
|
|
dual adaptor of phosphotyrosine and 3-phosphoinositides 1
|
[NCBI]
|
2.36896e-05
|
|
|
FCRL3
|
[NCBI]
|
2.36896e-05
|
|
|
SNRPD2
|
[NCBI]
|
2.36896e-05
|
|
|
DNMAP1
|
[NCBI]
|
2.36896e-05
|
|
|
UTP3
|
[NCBI]
|
2.36896e-05
|
|
|
fc fragment of iga and igm, receptor for
|
[NCBI]
|
2.36896e-05
|
|
|
SPAP1
|
[NCBI]
|
2.36896e-05
|
|
|
PLEKHA2
|
[NCBI]
|
2.36896e-05
|
|
|
PLXNC1
|
[NCBI]
|
2.36896e-05
|
|
|
DGCR6L
|
[NCBI]
|
2.36896e-05
|
|
|
DLL1
|
[NCBI]
|
2.30831e-05
|
|
|
MAP4K2
|
[NCBI]
|
2.30831e-05
|
|
|
CBL
|
[NCBI]
|
2.30831e-05
|
|
|
APOE
|
[NCBI]
|
2.28807e-05
|
|
|
AFP
|
[NCBI]
|
2.26341e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.2548e-05
|
|
|
GS2
|
[NCBI]
|
2.25184e-05
|
|
|
IS
|
[NCBI]
|
2.25184e-05
|
|
|
HLF
|
[NCBI]
|
2.2327e-05
|
|
|
CASP8
|
[NCBI]
|
2.2327e-05
|
|
|
ID2
|
[NCBI]
|
2.2327e-05
|
|
|
APRT
|
[NCBI]
|
2.21961e-05
|
|
|
MRE11A
|
[NCBI]
|
2.16155e-05
|
|
|
PPARA
|
[NCBI]
|
2.11671e-05
|
|
|
TNFRSF10B
|
[NCBI]
|
2.0854e-05
|
|
|
FRAP1
|
[NCBI]
|
2.07148e-05
|
|
|
CASP3
|
[NCBI]
|
2.03088e-05
|
|
|
MCP
|
[NCBI]
|
2.00403e-05
|
|
|
TAF4B
|
[NCBI]
|
1.99893e-05
|
|
|
HKR3
|
[NCBI]
|
1.99893e-05
|
|
|
cd27-binding protein
|
[NCBI]
|
1.99893e-05
|
|
|
ANXA11
|
[NCBI]
|
1.99893e-05
|
|
|
POLI
|
[NCBI]
|
1.99893e-05
|
|
|
IGHA1
|
[NCBI]
|
1.99893e-05
|
|
|
MCTS1
|
[NCBI]
|
1.99893e-05
|
|
|
SAMSN1
|
[NCBI]
|
1.99893e-05
|
|
|
ZBTB7
|
[NCBI]
|
1.99893e-05
|
|
|
POU2F2
|
[NCBI]
|
1.99893e-05
|
|
|
XLRL
|
[NCBI]
|
1.99893e-05
|
|
|
CD84
|
[NCBI]
|
1.99893e-05
|
|
|
ZNF43
|
[NCBI]
|
1.99893e-05
|
|
|
LRMP
|
[NCBI]
|
1.99893e-05
|
|
|
STX11
|
[NCBI]
|
1.99893e-05
|
|
|
LY75
|
[NCBI]
|
1.99893e-05
|
|
|
IL1R2
|
[NCBI]
|
1.99893e-05
|
|
|
HLA-DMA
|
[NCBI]
|
1.99893e-05
|
|
|
IL22RA2
|
[NCBI]
|
1.99893e-05
|
|
|
IGHD
|
[NCBI]
|
1.99893e-05
|
|
|
HLA-DRB5
|
[NCBI]
|
1.99893e-05
|
|
|
HCLS1
|
[NCBI]
|
1.99893e-05
|
|
|
TLE4
|
[NCBI]
|
1.99893e-05
|
|
|
UBD
|
[NCBI]
|
1.99893e-05
|
|
|
ICAM3
|
[NCBI]
|
1.99893e-05
|
|
|
C1QDC1
|
[NCBI]
|
1.99893e-05
|
|
|
RPS20
|
[NCBI]
|
1.99893e-05
|
|
|
AKAP8L
|
[NCBI]
|
1.99893e-05
|
|
|
GPR132
|
[NCBI]
|
1.99893e-05
|
|
|
DTX1
|
[NCBI]
|
1.99893e-05
|
|
|
POLM
|
[NCBI]
|
1.99893e-05
|
|
|
DOK3
|
[NCBI]
|
1.99893e-05
|
|
|
PTPN7
|
[NCBI]
|
1.99893e-05
|
|
|
MR1
|
[NCBI]
|
1.99893e-05
|
|
|
EPHA3
|
[NCBI]
|
1.99893e-05
|
|
|
SH3BP5
|
[NCBI]
|
1.99893e-05
|
|
|
HCK
|
[NCBI]
|
1.99893e-05
|
|
|
SCN3
|
[NCBI]
|
1.97376e-05
|
|
|
IL12A
|
[NCBI]
|
1.97063e-05
|
|
|
DYNLL2
|
[NCBI]
|
1.76103e-05
|
|
|
TREML1
|
[NCBI]
|
1.76103e-05
|
|
|
ICA1
|
[NCBI]
|
1.76103e-05
|
|
|
GPIAP1
|
[NCBI]
|
1.76103e-05
|
|
|
thymic stromal lymphopoietin
|
[NCBI]
|
1.76103e-05
|
|
|
CD5
|
[NCBI]
|
1.76103e-05
|
|
|
LPXN
|
[NCBI]
|
1.76103e-05
|
|
|
FANCF
|
[NCBI]
|
1.76103e-05
|
|
|
PDE1B
|
[NCBI]
|
1.76103e-05
|
|
|
TRAF5
|
[NCBI]
|
1.76103e-05
|
|
|
MIRN15A
|
[NCBI]
|
1.76103e-05
|
|
|
DOCK2
|
[NCBI]
|
1.76103e-05
|
|
|
TNIP2
|
[NCBI]
|
1.76103e-05
|
|
|
ARHGDIB
|
[NCBI]
|
1.76103e-05
|
|
|
IK
|
[NCBI]
|
1.76103e-05
|
|
|
NUCB1
|
[NCBI]
|
1.76103e-05
|
|
|
AMPD3
|
[NCBI]
|
1.76103e-05
|
|
|
MYBL2
|
[NCBI]
|
1.76103e-05
|
|
|
AIP
|
[NCBI]
|
1.76103e-05
|
|
|
suppressor of t-cell receptor signaling 1
|
[NCBI]
|
1.76103e-05
|
|
|
RPA3
|
[NCBI]
|
1.76103e-05
|
|
|
CD48
|
[NCBI]
|
1.76103e-05
|
|
|
PMAIP1
|
[NCBI]
|
1.76103e-05
|
|
|
CXCR7
|
[NCBI]
|
1.76103e-05
|
|
|
PLA2G6
|
[NCBI]
|
1.76103e-05
|
|
|
MSH5
|
[NCBI]
|
1.76103e-05
|
|
|
HMGB3
|
[NCBI]
|
1.76103e-05
|
|
|
CCR4
|
[NCBI]
|
1.76103e-05
|
|
|
NOX5
|
[NCBI]
|
1.76103e-05
|
|
|
SIGLEC5
|
[NCBI]
|
1.76103e-05
|
|
|
FOXP1
|
[NCBI]
|
1.76103e-05
|
|
|
RPA2
|
[NCBI]
|
1.76103e-05
|
|
|
NFKBIE
|
[NCBI]
|
1.76103e-05
|
|
|
ST6GAL1
|
[NCBI]
|
1.76103e-05
|
|
|
TP53BP1
|
[NCBI]
|
1.76103e-05
|
|
|
C4BPA
|
[NCBI]
|
1.76103e-05
|
|
|
RASSF5
|
[NCBI]
|
1.76103e-05
|
|
|
PIGA
|
[NCBI]
|
1.75708e-05
|
|
|
CD4
|
[NCBI]
|
1.75708e-05
|
|
|
TYMS
|
[NCBI]
|
1.73359e-05
|
|
|
CYBB
|
[NCBI]
|
1.7095e-05
|
|
|
DCK
|
[NCBI]
|
1.68204e-05
|
|
|
IL12B
|
[NCBI]
|
1.66389e-05
|
|
|
TNFSF11
|
[NCBI]
|
1.63847e-05
|
|
|
TLR10
|
[NCBI]
|
1.58587e-05
|
|
|
IRGM
|
[NCBI]
|
1.58587e-05
|
|
|
HLX1
|
[NCBI]
|
1.58587e-05
|
|
|
TSPAN32
|
[NCBI]
|
1.58587e-05
|
|
|
KLRD1
|
[NCBI]
|
1.58587e-05
|
|
|
RHOH
|
[NCBI]
|
1.58587e-05
|
|
|
TPP2
|
[NCBI]
|
1.58587e-05
|
|
|
B3GAT1
|
[NCBI]
|
1.58587e-05
|
|
|
LILRB4
|
[NCBI]
|
1.58587e-05
|
|
|
TNFRSF7
|
[NCBI]
|
1.58587e-05
|
|
|
ZFP36L1
|
[NCBI]
|
1.58587e-05
|
|
|
serine/threonine protein kinase 21
|
[NCBI]
|
1.58587e-05
|
|
|
FMO4
|
[NCBI]
|
1.58587e-05
|
|
|
RIPK3
|
[NCBI]
|
1.58587e-05
|
|
|
UBE2N
|
[NCBI]
|
1.58587e-05
|
|
|
SH2B3
|
[NCBI]
|
1.58587e-05
|
|
|
TROVE2
|
[NCBI]
|
1.58587e-05
|
|
|
CCNG1
|
[NCBI]
|
1.58587e-05
|
|
|
CD226
|
[NCBI]
|
1.58587e-05
|
|
|
HNRPA1
|
[NCBI]
|
1.58587e-05
|
|
|
ITGB3BP
|
[NCBI]
|
1.58587e-05
|
|
|
CRKL
|
[NCBI]
|
1.58587e-05
|
|
|
SDCBP
|
[NCBI]
|
1.58587e-05
|
|
|
PIK3CD
|
[NCBI]
|
1.58587e-05
|
|
|
NFIL3
|
[NCBI]
|
1.58587e-05
|
|
|
NHEJ1
|
[NCBI]
|
1.58587e-05
|
|
|
NFKB2
|
[NCBI]
|
1.58587e-05
|
|
|
TNFRSF14
|
[NCBI]
|
1.57809e-05
|
|
|
FANCC
|
[NCBI]
|
1.53764e-05
|
|
|
APOB
|
[NCBI]
|
1.51715e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.51673e-05
|
|
|
JAK1
|
[NCBI]
|
1.46117e-05
|
|
|
FGR
|
[NCBI]
|
1.44766e-05
|
|
|
CD24
|
[NCBI]
|
1.44766e-05
|
|
|
SIPA1
|
[NCBI]
|
1.44766e-05
|
|
|
CDC2L2
|
[NCBI]
|
1.44766e-05
|
|
|
RENT1
|
[NCBI]
|
1.44766e-05
|
|
|
LST1
|
[NCBI]
|
1.44766e-05
|
|
|
SEMA4A
|
[NCBI]
|
1.44766e-05
|
|
|
CD7
|
[NCBI]
|
1.44766e-05
|
|
|
PDE4B
|
[NCBI]
|
1.44766e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
1.44766e-05
|
|
|
FER
|
[NCBI]
|
1.44766e-05
|
|
|
TICAM1
|
[NCBI]
|
1.44766e-05
|
|
|
IL5RA
|
[NCBI]
|
1.44766e-05
|
|
|
FEN1
|
[NCBI]
|
1.44766e-05
|
|
|
PDIA3
|
[NCBI]
|
1.44766e-05
|
|
|
CBLB
|
[NCBI]
|
1.44766e-05
|
|
|
BIK
|
[NCBI]
|
1.44766e-05
|
|
|
CD86
|
[NCBI]
|
1.44766e-05
|
|
|
A4GALT
|
[NCBI]
|
1.44766e-05
|
|
|
DDX20
|
[NCBI]
|
1.44766e-05
|
|
|
MAP3K2
|
[NCBI]
|
1.44766e-05
|
|
|
DNASE1
|
[NCBI]
|
1.44766e-05
|
|
|
SATB2
|
[NCBI]
|
1.44766e-05
|
|
|
SH2B1
|
[NCBI]
|
1.44766e-05
|
|
|
CASP10
|
[NCBI]
|
1.44766e-05
|
|
|
AHNAK
|
[NCBI]
|
1.44766e-05
|
|
|
SELPLG
|
[NCBI]
|
1.44766e-05
|
|
|
UCHL3
|
[NCBI]
|
1.44766e-05
|
|
|
IL2RA
|
[NCBI]
|
1.39e-05
|
|
|
BAX
|
[NCBI]
|
1.35621e-05
|
|
|
RUNX1
|
[NCBI]
|
1.35621e-05
|
|
|
omenn syndrome
|
[NCBI]
|
1.34759e-05
|
|
|
RNASE3
|
[NCBI]
|
1.34436e-05
|
|
|
BCL11A
|
[NCBI]
|
1.33388e-05
|
|
|
IL12RB2
|
[NCBI]
|
1.33388e-05
|
|
|
LHX2
|
[NCBI]
|
1.33388e-05
|
|
|
CD83
|
[NCBI]
|
1.33388e-05
|
|
|
RPA1
|
[NCBI]
|
1.33388e-05
|
|
|
CASP2
|
[NCBI]
|
1.33388e-05
|
|
|
GTF2I
|
[NCBI]
|
1.33388e-05
|
|
|
LMO7
|
[NCBI]
|
1.33388e-05
|
|
|
KPNA2
|
[NCBI]
|
1.33388e-05
|
|
|
LCP2
|
[NCBI]
|
1.33388e-05
|
|
|
IL1R1
|
[NCBI]
|
1.33388e-05
|
|
|
TICAM2
|
[NCBI]
|
1.33388e-05
|
|
|
CASP9
|
[NCBI]
|
1.33388e-05
|
|
|
DUSP5
|
[NCBI]
|
1.33388e-05
|
|
|
XRCC4
|
[NCBI]
|
1.33388e-05
|
|
|
CD6
|
[NCBI]
|
1.33388e-05
|
|
|
PBEF1
|
[NCBI]
|
1.33388e-05
|
|
|
RPS13
|
[NCBI]
|
1.33388e-05
|
|
|
BHLHB2
|
[NCBI]
|
1.33388e-05
|
|
|
CRTC2
|
[NCBI]
|
1.33388e-05
|
|
|
FANCE
|
[NCBI]
|
1.33388e-05
|
|
|
IRAK4
|
[NCBI]
|
1.33388e-05
|
|
|
PDE4A
|
[NCBI]
|
1.33388e-05
|
|
|
IGKV
|
[NCBI]
|
1.33388e-05
|
|
|
GNLY
|
[NCBI]
|
1.33388e-05
|
|
|
CCL4
|
[NCBI]
|
1.33388e-05
|
|
|
MYST3
|
[NCBI]
|
1.33388e-05
|
|
|
MAPK10
|
[NCBI]
|
1.33388e-05
|
|
|
STAT1
|
[NCBI]
|
1.31619e-05
|
|
|
GAL
|
[NCBI]
|
1.2743e-05
|
|
|
BCR
|
[NCBI]
|
1.25875e-05
|
|
|
FOXN1
|
[NCBI]
|
1.23745e-05
|
|
|
HTLVR
|
[NCBI]
|
1.23745e-05
|
|
|
TYK2
|
[NCBI]
|
1.23745e-05
|
|
|
PDCD2
|
[NCBI]
|
1.23745e-05
|
|
|
ITCH
|
[NCBI]
|
1.23745e-05
|
|
|
MCL1
|
[NCBI]
|
1.23745e-05
|
|
|
PTPN22
|
[NCBI]
|
1.23745e-05
|
|
|
KLRC1
|
[NCBI]
|
1.23745e-05
|
|
|
CD38
|
[NCBI]
|
1.23745e-05
|
|
|
PPM1D
|
[NCBI]
|
1.23745e-05
|
|
|
BCL3
|
[NCBI]
|
1.23745e-05
|
|
|
G22P1
|
[NCBI]
|
1.23745e-05
|
|
|
STMN1
|
[NCBI]
|
1.23745e-05
|
|
|
IGHV
|
[NCBI]
|
1.23745e-05
|
|
|
MDC1
|
[NCBI]
|
1.23745e-05
|
|
|
ELK3
|
[NCBI]
|
1.23745e-05
|
|
|
TPD52
|
[NCBI]
|
1.23745e-05
|
|
|
CD74
|
[NCBI]
|
1.23745e-05
|
|
|
DDX6
|
[NCBI]
|
1.23745e-05
|
|
|
OGG1
|
[NCBI]
|
1.23745e-05
|
|
|
DAPK1
|
[NCBI]
|
1.23745e-05
|
|
|
CCL22
|
[NCBI]
|
1.21957e-05
|
|
|
ABL1
|
[NCBI]
|
1.20287e-05
|
|
|
IL10
|
[NCBI]
|
1.20287e-05
|
|
|
AGS1
|
[NCBI]
|
1.18821e-05
|
|
|
RIPK1
|
[NCBI]
|
1.17495e-05
|
|
|
CCR6
|
[NCBI]
|
1.15399e-05
|
|
|
FES
|
[NCBI]
|
1.15399e-05
|
|
|
BCL2L1
|
[NCBI]
|
1.15399e-05
|
|
|
CD81
|
[NCBI]
|
1.15399e-05
|
|
|
MALT1
|
[NCBI]
|
1.15399e-05
|
|
|
WASF1
|
[NCBI]
|
1.15399e-05
|
|
|
IL2RB
|
[NCBI]
|
1.15399e-05
|
|
|
ICSBP1
|
[NCBI]
|
1.15399e-05
|
|
|
ITGA4
|
[NCBI]
|
1.15399e-05
|
|
|
LTB4R
|
[NCBI]
|
1.15399e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
1.15399e-05
|
|
|
SFRS1
|
[NCBI]
|
1.15399e-05
|
|
|
TMSB4X
|
[NCBI]
|
1.15399e-05
|
|
|
FADD
|
[NCBI]
|
1.15399e-05
|
|
|
PLCB2
|
[NCBI]
|
1.15399e-05
|
|
|
CARD11
|
[NCBI]
|
1.15399e-05
|
|
|
PLCB3
|
[NCBI]
|
1.15399e-05
|
|
|
CDC2L1
|
[NCBI]
|
1.15399e-05
|
|
|
DAXX
|
[NCBI]
|
1.15399e-05
|
|
|
CD
|
[NCBI]
|
1.09777e-05
|
|
|
DSG3
|
[NCBI]
|
1.09597e-05
|
|
|
HOXA10
|
[NCBI]
|
1.08062e-05
|
|
|
TCF4
|
[NCBI]
|
1.08062e-05
|
|
|
AGRN
|
[NCBI]
|
1.08062e-05
|
|
|
CD3G
|
[NCBI]
|
1.08062e-05
|
|
|
CD28
|
[NCBI]
|
1.08062e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
1.08062e-05
|
|
|
PIM1
|
[NCBI]
|
1.08062e-05
|
|
|
EDG1
|
[NCBI]
|
1.08062e-05
|
|
|
BBC3
|
[NCBI]
|
1.08062e-05
|
|
|
SMAD7
|
[NCBI]
|
1.08062e-05
|
|
|
RAC2
|
[NCBI]
|
1.08062e-05
|
|
|
ITPR1
|
[NCBI]
|
1.08062e-05
|
|
|
VDR
|
[NCBI]
|
1.06576e-05
|
|
|
PTHLH
|
[NCBI]
|
1.05827e-05
|
|
|
INSR
|
[NCBI]
|
1.05376e-05
|
|
|
PTK2
|
[NCBI]
|
1.05097e-05
|
|
|
BRCA2
|
[NCBI]
|
1.02341e-05
|
|
|
DFFB
|
[NCBI]
|
1.02341e-05
|
|
|
NGFR
|
[NCBI]
|
1.02244e-05
|
|
|
SPN
|
[NCBI]
|
1.01528e-05
|
|
|
FYB
|
[NCBI]
|
1.01528e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
1.01528e-05
|
|
|
EZH2
|
[NCBI]
|
1.01528e-05
|
|
|
TYROBP
|
[NCBI]
|
1.01528e-05
|
|
|
CXCR3
|
[NCBI]
|
1.01528e-05
|
|
|
CCND3
|
[NCBI]
|
1.01528e-05
|
|
|
PDCD1
|
[NCBI]
|
1.01528e-05
|
|
|
SYK
|
[NCBI]
|
1.01528e-05
|
|
|
CCL3
|
[NCBI]
|
9.56528e-06
|
|
|
P2RX7
|
[NCBI]
|
9.56528e-06
|
|
|
SNN
|
[NCBI]
|
9.56528e-06
|
|
|
GPR30
|
[NCBI]
|
9.56528e-06
|
|
|
NCF2
|
[NCBI]
|
9.56528e-06
|
|
|
LDLRAP1
|
[NCBI]
|
9.56528e-06
|
|
|
GADD45A
|
[NCBI]
|
9.56528e-06
|
|
|
HTATIP
|
[NCBI]
|
9.56528e-06
|
|
|
NEDD9
|
[NCBI]
|
9.56528e-06
|
|
|
MFGE8
|
[NCBI]
|
9.56528e-06
|
|
|
CFI
|
[NCBI]
|
9.56528e-06
|
|
|
SPP1
|
[NCBI]
|
9.34608e-06
|
|
|
TTR
|
[NCBI]
|
9.15488e-06
|
|
|
SCGF
|
[NCBI]
|
9.0325e-06
|
|
|
UCHL1
|
[NCBI]
|
9.0325e-06
|
|
|
GFI1
|
[NCBI]
|
9.0325e-06
|
|
|
ZP3
|
[NCBI]
|
9.0325e-06
|
|
|
EIF2C2
|
[NCBI]
|
9.0325e-06
|
|
|
PRKCZ
|
[NCBI]
|
9.0325e-06
|
|
|
JARID1D
|
[NCBI]
|
9.0325e-06
|
|
|
FA
|
[NCBI]
|
9.00534e-06
|
|
|
OSM
|
[NCBI]
|
8.8139e-06
|
|
|
RAB27A
|
[NCBI]
|
8.54603e-06
|
|
|
HLA-B
|
[NCBI]
|
8.54603e-06
|
|
|
MOS
|
[NCBI]
|
8.54603e-06
|
|
|
APAF1
|
[NCBI]
|
8.54603e-06
|
|
|
MADHIP
|
[NCBI]
|
8.54603e-06
|
|
|
FYN
|
[NCBI]
|
8.54603e-06
|
|
|
SDC1
|
[NCBI]
|
8.54603e-06
|
|
|
ANGPT2
|
[NCBI]
|
8.54603e-06
|
|
|
HLA-G
|
[NCBI]
|
8.54603e-06
|
|
|
DBA
|
[NCBI]
|
8.30193e-06
|
|
|
CYP1A1
|
[NCBI]
|
8.22583e-06
|
|
|
PF4
|
[NCBI]
|
8.18774e-06
|
|
|
LEF1
|
[NCBI]
|
8.09924e-06
|
|
|
SMAD3
|
[NCBI]
|
8.09924e-06
|
|
|
SOCS2
|
[NCBI]
|
8.09924e-06
|
|
|
EPB41
|
[NCBI]
|
8.09924e-06
|
|
|
ANP32A
|
[NCBI]
|
8.09924e-06
|
|
|
CBFA2T1
|
[NCBI]
|
8.09924e-06
|
|
|
C4B
|
[NCBI]
|
8.09924e-06
|
|
|
NCF1
|
[NCBI]
|
8.09924e-06
|
|
|
EBI3
|
[NCBI]
|
8.09924e-06
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
8.0951e-06
|
|
|
GJA1
|
[NCBI]
|
7.94948e-06
|
|
|
JAK2
|
[NCBI]
|
7.7175e-06
|
|
|
JMJD6
|
[NCBI]
|
7.68682e-06
|
|
|
SPG7
|
[NCBI]
|
7.68682e-06
|
|
|
RCC1
|
[NCBI]
|
7.68682e-06
|
|
|
GAD2
|
[NCBI]
|
7.68682e-06
|
|
|
THY1
|
[NCBI]
|
7.68682e-06
|
|
|
XRCC9
|
[NCBI]
|
7.68682e-06
|
|
|
TNXB
|
[NCBI]
|
7.68682e-06
|
|
|
BAK1
|
[NCBI]
|
7.68682e-06
|
|
|
EP300
|
[NCBI]
|
7.68682e-06
|
|
|
HMOX1
|
[NCBI]
|
7.68682e-06
|
|
|
IKZF1
|
[NCBI]
|
7.68682e-06
|
|
|
CEACAM5
|
[NCBI]
|
7.51991e-06
|
|
|
GPI
|
[NCBI]
|
7.4556e-06
|
|
|
VCAM1
|
[NCBI]
|
7.30448e-06
|
|
|
PTGS1
|
[NCBI]
|
7.30448e-06
|
|
|
NFATC2
|
[NCBI]
|
7.30448e-06
|
|
|
PAK2
|
[NCBI]
|
7.30448e-06
|
|
|
CD1D
|
[NCBI]
|
7.30448e-06
|
|
|
MICA
|
[NCBI]
|
7.30448e-06
|
|
|
TLR3
|
[NCBI]
|
7.17855e-06
|
|
|
IFNA1
|
[NCBI]
|
7.17855e-06
|
|
|
NOTCH1
|
[NCBI]
|
7.17855e-06
|
|
|
GHRH
|
[NCBI]
|
7.10441e-06
|
|
|
donohue syndrome
|
[NCBI]
|
7.09328e-06
|
|
|
EDC
|
[NCBI]
|
7.09328e-06
|
|
|
ADAM10
|
[NCBI]
|
6.94866e-06
|
|
|
PGM3
|
[NCBI]
|
6.94866e-06
|
|
|
IL17A
|
[NCBI]
|
6.94866e-06
|
|
|
ABO
|
[NCBI]
|
6.94866e-06
|
|
|
TXNIP
|
[NCBI]
|
6.94866e-06
|
|
|
MYB
|
[NCBI]
|
6.94866e-06
|
|
|
LTA
|
[NCBI]
|
6.94866e-06
|
|
|
TF
|
[NCBI]
|
6.92457e-06
|
|
|
EEA1
|
[NCBI]
|
6.61642e-06
|
|
|
SN
|
[NCBI]
|
6.61642e-06
|
|
|
FUS
|
[NCBI]
|
6.61642e-06
|
|
|
AT
|
[NCBI]
|
6.59157e-06
|
|
|
F2R
|
[NCBI]
|
6.57742e-06
|
|
|
STAT5A
|
[NCBI]
|
6.48346e-06
|
|
|
ACH
|
[NCBI]
|
6.47182e-06
|
|
|
XDH
|
[NCBI]
|
6.40428e-06
|
|
|
ACP5
|
[NCBI]
|
6.36515e-06
|
|
|
FOS
|
[NCBI]
|
6.30526e-06
|
|
|
IRF1
|
[NCBI]
|
6.30526e-06
|
|
|
CMM2
|
[NCBI]
|
6.19583e-06
|
|
|
SOD2
|
[NCBI]
|
6.1856e-06
|
|
|
CCL17
|
[NCBI]
|
6.02624e-06
|
|
|
CYP2A6
|
[NCBI]
|
6.01308e-06
|
|
|
KLF6
|
[NCBI]
|
6.01308e-06
|
|
|
TRAF6
|
[NCBI]
|
6.01308e-06
|
|
|
CCND1
|
[NCBI]
|
5.76766e-06
|
|
|
MAPK8
|
[NCBI]
|
5.73807e-06
|
|
|
KLF2
|
[NCBI]
|
5.73807e-06
|
|
|
TSG101
|
[NCBI]
|
5.73807e-06
|
|
|
G6PC2
|
[NCBI]
|
5.73807e-06
|
|
|
RECQL3
|
[NCBI]
|
5.73807e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
5.64235e-06
|
|
|
DIABLO
|
[NCBI]
|
5.47867e-06
|
|
|
MAP3K7
|
[NCBI]
|
5.47867e-06
|
|
|
ITGB1
|
[NCBI]
|
5.47867e-06
|
|
|
MPL
|
[NCBI]
|
5.47867e-06
|
|
|
MAP4K1
|
[NCBI]
|
5.47867e-06
|
|
|
IFNGR1
|
[NCBI]
|
5.47867e-06
|
|
|
MB
|
[NCBI]
|
5.40664e-06
|
|
|
IL3
|
[NCBI]
|
5.39935e-06
|
|
|
SLC6A4
|
[NCBI]
|
5.26389e-06
|
|
|
LCK
|
[NCBI]
|
5.23351e-06
|
|
|
CPM
|
[NCBI]
|
5.23351e-06
|
|
|
TCRB
|
[NCBI]
|
5.23351e-06
|
|
|
GJA8
|
[NCBI]
|
5.23351e-06
|
|
|
NOS2A
|
[NCBI]
|
5.23351e-06
|
|
|
HDC
|
[NCBI]
|
5.17752e-06
|
|
|
LPO
|
[NCBI]
|
5.16607e-06
|
|
|
PRKAR1A
|
[NCBI]
|
5.00141e-06
|
|
|
HDAC4
|
[NCBI]
|
5.00141e-06
|
|
|
ATF6
|
[NCBI]
|
5.00141e-06
|
|
|
FANCA
|
[NCBI]
|
5.00141e-06
|
|
|
ALB
|
[NCBI]
|
4.92052e-06
|
|
|
CD59
|
[NCBI]
|
4.78132e-06
|
|
|
PPIB
|
[NCBI]
|
4.78132e-06
|
|
|
FOXO3A
|
[NCBI]
|
4.78132e-06
|
|
|
TNFRSF6B
|
[NCBI]
|
4.78132e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.66944e-06
|
|
|
ATM
|
[NCBI]
|
4.62231e-06
|
|
|
DAP
|
[NCBI]
|
4.57232e-06
|
|
|
NBS1
|
[NCBI]
|
4.57232e-06
|
|
|
CD
|
[NCBI]
|
4.50525e-06
|
|
|
ACPP
|
[NCBI]
|
4.49957e-06
|
|
|
CD8A
|
[NCBI]
|
4.37359e-06
|
|
|
DSG1
|
[NCBI]
|
4.37359e-06
|
|
|
IL18
|
[NCBI]
|
4.37359e-06
|
|
|
SLC3A2
|
[NCBI]
|
4.37359e-06
|
|
|
STAT4
|
[NCBI]
|
4.18439e-06
|
|
|
PML
|
[NCBI]
|
4.18439e-06
|
|
|
ETV6
|
[NCBI]
|
4.18439e-06
|
|
|
UMOD
|
[NCBI]
|
4.18439e-06
|
|
|
IAPP
|
[NCBI]
|
4.16983e-06
|
|
|
MAG
|
[NCBI]
|
4.10078e-06
|
|
|
RP1
|
[NCBI]
|
4.0224e-06
|
|
|
STAT5B
|
[NCBI]
|
4.00407e-06
|
|
|
fucosidosis
|
[NCBI]
|
4.00407e-06
|
|
|
CHUK
|
[NCBI]
|
3.83203e-06
|
|
|
DNMT3B
|
[NCBI]
|
3.83203e-06
|
|
|
GJA5
|
[NCBI]
|
3.83203e-06
|
|
|
HDAC3
|
[NCBI]
|
3.83203e-06
|
|
|
CDKN1A
|
[NCBI]
|
3.83203e-06
|
|
|
MDM2
|
[NCBI]
|
3.83203e-06
|
|
|
TNFRSF1B
|
[NCBI]
|
3.83203e-06
|
|
|
CDK6
|
[NCBI]
|
3.83203e-06
|
|
|
SDS
|
[NCBI]
|
3.73188e-06
|
|
|
GC
|
[NCBI]
|
3.66774e-06
|
|
|
PSEN2
|
[NCBI]
|
3.66774e-06
|
|
|
RAC1
|
[NCBI]
|
3.66774e-06
|
|
|
SOCS1
|
[NCBI]
|
3.51071e-06
|
|
|
CML
|
[NCBI]
|
3.44292e-06
|
|
|
malaria, susceptibility to
|
[NCBI]
|
3.44292e-06
|
|
|
IGER
|
[NCBI]
|
3.44292e-06
|
|
|
MS
|
[NCBI]
|
3.3797e-06
|
|
|
TCRA
|
[NCBI]
|
3.3605e-06
|
|
|
LIFR
|
[NCBI]
|
3.3605e-06
|
|
|
STAT3
|
[NCBI]
|
3.30827e-06
|
|
|
B2M
|
[NCBI]
|
3.21672e-06
|
|
|
TIMP1
|
[NCBI]
|
3.21672e-06
|
|
|
HRG
|
[NCBI]
|
3.21672e-06
|
|
|
CUTL1
|
[NCBI]
|
3.21672e-06
|
|
|
PTEN
|
[NCBI]
|
3.19965e-06
|
|
|
G6PD
|
[NCBI]
|
3.00459e-06
|
|
|
ADAM17
|
[NCBI]
|
2.94698e-06
|
|
|
PDCD8
|
[NCBI]
|
2.9267e-06
|
|
|
INS
|
[NCBI]
|
2.63021e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.61154e-06
|
|
|
ASL
|
[NCBI]
|
2.58228e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
2.51248e-06
|
|
|
EPO
|
[NCBI]
|
2.48317e-06
|
|
|
WRN
|
[NCBI]
|
2.45077e-06
|
|
|
MYH11
|
[NCBI]
|
2.36268e-06
|
|
|
ZNF145
|
[NCBI]
|
2.36268e-06
|
|
|
CSF2
|
[NCBI]
|
2.25926e-06
|
|
|
CP
|
[NCBI]
|
2.21015e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
2.18105e-06
|
|
|
GCK
|
[NCBI]
|
2.0642e-06
|
|
|
NFKB1
|
[NCBI]
|
1.97222e-06
|
|
|
PGK1
|
[NCBI]
|
1.97222e-06
|
|
|
MTAP
|
[NCBI]
|
1.88371e-06
|
|
|
GRB2
|
[NCBI]
|
1.88371e-06
|
|
|
ELN
|
[NCBI]
|
1.88371e-06
|
|
|
CD47
|
[NCBI]
|
1.71656e-06
|
|
|
RLBP1
|
[NCBI]
|
1.71656e-06
|
|
|
TSHR
|
[NCBI]
|
1.63764e-06
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
1.58953e-06
|
|
|
IBD1
|
[NCBI]
|
1.58953e-06
|
|
|
SST
|
[NCBI]
|
1.47255e-06
|
|
|
CHS
|
[NCBI]
|
1.46503e-06
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.36916e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.36916e-06
|
|
|
SLC18A2
|
[NCBI]
|
1.35026e-06
|
|
|
GHR
|
[NCBI]
|
1.32558e-06
|
|
|
FBN1
|
[NCBI]
|
1.28495e-06
|
|
|
KLF4
|
[NCBI]
|
1.22208e-06
|
|
|
TGFB1
|
[NCBI]
|
1.16154e-06
|
|
|
DNMT1
|
[NCBI]
|
1.07538e-06
|
|
|
EPOR
|
[NCBI]
|
9.43581e-07
|
|
|
SERPINA6
|
[NCBI]
|
9.43581e-07
|
|
|
SRF
|
[NCBI]
|
9.33961e-07
|
|
|
TP53
|
[NCBI]
|
8.92848e-07
|
|
|
LPI
|
[NCBI]
|
8.45158e-07
|
|
|
PARP1
|
[NCBI]
|
8.43103e-07
|
|
|
LDLR
|
[NCBI]
|
7.9449e-07
|
|
|
FAAH
|
[NCBI]
|
7.46917e-07
|
|
|
APS1
|
[NCBI]
|
6.90549e-07
|
|
|
PENK
|
[NCBI]
|
6.68622e-07
|
|
|
MUC1
|
[NCBI]
|
5.68144e-07
|
|
|
FGFR3
|
[NCBI]
|
5.67968e-07
|
|
|
JMML
|
[NCBI]
|
5.49646e-07
|
|
|
OCP
|
[NCBI]
|
5.49646e-07
|
|
|
TNFSF10
|
[NCBI]
|
5.26939e-07
|
|
|
ALK
|
[NCBI]
|
4.91675e-07
|
|
|
THPO
|
[NCBI]
|
4.86889e-07
|
|
|
PLK1
|
[NCBI]
|
3.90196e-07
|
|
|
ZFP36
|
[NCBI]
|
3.67157e-07
|
|
|
RASA1
|
[NCBI]
|
3.54714e-07
|
|
|
CDK4
|
[NCBI]
|
3.3699e-07
|
|
|
PAEP
|
[NCBI]
|
3.15016e-07
|
|
|
ASS
|
[NCBI]
|
2.90761e-07
|
|
|
PPARG
|
[NCBI]
|
2.05144e-07
|
|
|
HP
|
[NCBI]
|
2.03075e-07
|
|
|
PI
|
[NCBI]
|
1.97397e-07
|
|
|
DBI
|
[NCBI]
|
1.70741e-07
|
|
|
SLPI
|
[NCBI]
|
1.70741e-07
|
|
|
PTK2B
|
[NCBI]
|
1.52146e-07
|
|
|
PRLR
|
[NCBI]
|
1.36482e-07
|
|
|
HMBS
|
[NCBI]
|
1.21782e-07
|
|
|
PPIA
|
[NCBI]
|
9.51834e-08
|
|
|
CGD
|
[NCBI]
|
6.8447e-08
|
|
|
TNFRSF11B
|
[NCBI]
|
5.8103e-08
|
|
|
FOP
|
[NCBI]
|
5.6692e-08
|
|
|
TLR2
|
[NCBI]
|
5.18553e-08
|
|
|
CDK2
|
[NCBI]
|
5.18553e-08
|
|
|
PSEN1
|
[NCBI]
|
3.47188e-08
|
|
|
MITF
|
[NCBI]
|
1.83335e-08
|
|
|
COMP
|
[NCBI]
|
7.05417e-09
|
|
|
PLG
|
[NCBI]
|
1.68832e-10
|
|